×

Orexigen soars on drug data

5:30 PM ET Wed, 4 March 2015

Orexigan soared 11 percent in today's trade following the release of the drug-maker's positive data on its diet pill, Contrave, without FDA approval. Details, with CNBC's Meg Tirrell.